drugset

drugset / Trial / NCT05126147

Hydroxychloroquine in Mild Graves' Orbitopathy

NCT05126147 ↗

Phase 4 Recruiting 108 enrolled National Taiwan University Hospital

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is aimed to investigate the effect of hydroxychloroquine in patients with mild Graves' orbitopathy (GO).

Timeline

Start: 2022-03-21
Primary completion: 2025-09-30
Completion: 2026-12-31

Publications

Lin CH, Wei YH, Lu JY, Li HY, Lee CW, Yang CY, Chang CH, Wu WC, Wang CY, Shih SR. A randomized controlled trial on the effect of hydroxychloroquine in mild Graves' orbitopathy (GO-HCQ): study protocol. Trials. 2025 Aug 4;26(1):272. doi: 10.1186/s13063-025-09002-6.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hydroxychloroquine	Small molecule	200 mg	Oral

Indications